Jane Street
FMED icon

Jane Street’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Jane Street’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Sell
53,106
-38,308
-42% -$996K ﹤0.01% 5926
2025
Q4 		$2.47M Buy
91,414
+44,630
+95% +$1.2M ﹤0.01% 4420
2025
Q3 		$1.17M Buy
46,784
+26,157
+127% +$632K ﹤0.01% 5970
2025
Q2 		$494K Sell
20,627
-45,755
-69% -$1.07M ﹤0.01% 6947
2025
Q1 		$1.57M Buy
66,382
+499
+0.8% +$12.6K ﹤0.01% 4771
2024
Q4 		$1.62M Buy
65,883
+4,541
+7% +$117K ﹤0.01% 4484
2024
Q3 		$1.61M Buy
61,342
+40,924
+200% +$1.03M ﹤0.01% 4924
2024
Q2 		$491K Sell
20,418
-17,936
-47% -$433K ﹤0.01% 7048
2024
Q1 		$979K Sell
38,354
-73,891
-66% -$1.83M ﹤0.01% 5454
2023
Q4 		$2.72M Buy
112,245
+79,246
+240% +$1.72M ﹤0.01% 3797
2023
Q3 		$730K Sell
32,999
-3,439
-9% -$82.3K ﹤0.01% 5649
2023
Q2 		$915K Buy
+36,438
New +$916K ﹤0.01% 5340

Other funds holding FMED

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
BW
BXM Wealth Englewood, Colorado $184M AUM 36.28% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street's FMED Position: Q1 2026 in Review

Jane Street reduced its Fidelity Disruptive Medicine ETF (FMED) stake by 42% in Q1 2026, selling an estimated $996K and leaving 53,106 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #5926.

Jane Street first reported a position in FMED in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.72M in Q4 2023. 11 funds tracked by Wall St. Rank hold FMED as of Q1 2026.

  • Jane Street held 53,106 shares of Fidelity Disruptive Medicine ETF worth $1.3M as of Q1 2026.
  • Jane Street sold 38,308 Fidelity Disruptive Medicine ETF shares in Q1 2026, an estimated $996K.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5926 holding.
  • Jane Street first reported a position in Fidelity Disruptive Medicine ETF in Q2 2023 and has held it in 12 quarters since.
  • Jane Street's Fidelity Disruptive Medicine ETF position peaked at $2.72M in Q4 2023.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.